Your browser doesn't support javascript.
loading
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.
Tung, Nadine M; Robson, Mark E; Ventz, Steffen; Santa-Maria, Cesar A; Nanda, Rita; Marcom, Paul K; Shah, Payal D; Ballinger, Tarah J; Yang, Eddy S; Vinayak, Shaveta; Melisko, Michelle; Brufsky, Adam; DeMeo, Michelle; Jenkins, Colby; Domchek, Susan; D'Andrea, Alan; Lin, Nancy U; Hughes, Melissa E; Carey, Lisa A; Wagle, Nick; Wulf, Gerburg M; Krop, Ian E; Wolff, Antonio C; Winer, Eric P; Garber, Judy E.
Afiliación
  • Tung NM; Beth Israel Deaconess Medical Center, Boston, MA.
  • Robson ME; Harvard Medical School, Boston, MA.
  • Ventz S; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Santa-Maria CA; Dana-Farber Cancer Institute, Boston, MA.
  • Nanda R; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
  • Marcom PK; The University of Chicago, Chicago, IL.
  • Shah PD; Duke University Medical Center, Durham, NC.
  • Ballinger TJ; Basser Center for BRCA, University of Pennsylvania, Philadelphia, PA.
  • Yang ES; Indiana University School of Medicine, Indianapolis, IN.
  • Vinayak S; University of Alabama at Birmingham, Birmingham, AL.
  • Melisko M; University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA.
  • Brufsky A; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.
  • DeMeo M; Division of Hematology Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Jenkins C; Dana-Farber Cancer Institute, Boston, MA.
  • Domchek S; Beth Israel Deaconess Medical Center, Boston, MA.
  • D'Andrea A; Basser Center for BRCA, University of Pennsylvania, Philadelphia, PA.
  • Lin NU; Harvard Medical School, Boston, MA.
  • Hughes ME; Dana-Farber Cancer Institute, Boston, MA.
  • Carey LA; Harvard Medical School, Boston, MA.
  • Wagle N; Dana-Farber Cancer Institute, Boston, MA.
  • Wulf GM; Dana-Farber Cancer Institute, Boston, MA.
  • Krop IE; University of North Carolina, Chapel Hill, NC.
  • Wolff AC; Harvard Medical School, Boston, MA.
  • Winer EP; Dana-Farber Cancer Institute, Boston, MA.
  • Garber JE; Beth Israel Deaconess Medical Center, Boston, MA.
J Clin Oncol ; 38(36): 4274-4282, 2020 12 20.
Article en En | MEDLINE | ID: mdl-33119476
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ftalazinas / Piperazinas / Neoplasias de la Mama / Recombinación Homóloga / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Marruecos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ftalazinas / Piperazinas / Neoplasias de la Mama / Recombinación Homóloga / Inhibidores de Poli(ADP-Ribosa) Polimerasas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Marruecos